http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005056016-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate | 2004-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2007-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2005056016-A1 |
titleOfInvention | Preventive and / or therapeutic agent for higher brain dysfunction |
abstract | (Wherein R 1 , R 2 and R 3 are the same or different and each represents a hydrogen atom, lower alkyl, lower alkenyl or lower alkynyl; R 4 is cycloalkyl, — (CH 2 ) n—R 5 or the above formula ( II), and X 1 and X 2 are the same or different and represent an oxygen atom or a sulfur atom) For example, a prophylactic and / or therapeutic agent for higher brain dysfunction containing a xanthine derivative represented by the above formula (I) or a pharmacologically acceptable salt thereof as an active ingredient is provided. |
priorityDate | 2003-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.